Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Capital Expenditure Over TimeExpanding
Percentile Rank83
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-6.47M
↑ 62% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-17.13M
Historical baseline
PeriodValueYoY Change
TTM$-6.47M+52.8%
2024$-13.70M-14.6%
2023$-11.96M+68.0%
2022$-37.36M+6.1%
2021$-39.80M-490.9%
2020$-6.74M-72.3%
2019$-3.91M-